Stock Price
6.23
Daily Change
-0.23 -3.56%
Monthly
-0.80%
Yearly
60.57%
Q2 Forecast
6.10

Ardelyx reported $5.1M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Abbott USD 1.85B 684M Mar/2026
Amgen USD 3.83B 130M Mar/2026
Ardelyx USD 5.1M 2.02M Dec/2025
aTyr Pharma USD 24.47M 24.7M Dec/2025
Corcept Therapeutics USD -49.6M 54.09M Mar/2026
Curis USD -7.88M 4.31M Dec/2025
Sanofi EUR 3.74B 2.23B Sep/2025
TG Therapeutics USD 34.8M 15.7M Mar/2026
United Therapeutics USD 325.8M 340.4M Mar/2026
Xoma USD -10.08M 4.4M Jun/2024